Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, B-Cell 2 Neoplasms 1 Neoplasm Metastasis 1 Metastatic Solid Tumors 1 Hemorrhage 1 Diarrhea 1 Colitis 1

Interventions

Octreotide 2 telotristat ethyl 1 isatuximab 1 ceterizine hydrochloride 1 capivasertib 1 cabazitaxel 1 XRP6258 1 Prednisone 1 Loperamide 1 Leucovorin 1 Lapatinib 1 Irinotecan 1 Injections 1 Granulocyte Colony-Stimulating Factor 1 Fulvestrant 1 Fluorouracil 1 Filgrastim 1 Drugs, Investigational 1 Cyclophosphamide 1 Colesevelam Hydrochloride 1 Cell- and Tissue-Based Therapy 1 Capecitabine 1 Calcium Aluminosilicate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Diarrhea × Cell- and Tissue-Based Therapy × Clear all

NCT02814864 2021-08-03

PRISME

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Colitis, Diarrhea, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡